×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
1546 views

Modérateur :
Dr Eric-Charles Antoine

Intervenants :
Pr Paul Cottu
Dr Marie-Ange Mourret-Reynier

Agenda

18:00 Introduction
Dr Eric-Charles Antoine
 
18:05 Cancer du sein métastatique RH+/HER2- : apport des iCDK4/6 et perspectives
Pr Paul Cottu
 

18:35

Cancer du sein métastatique HER2+ : évolution du paysage thérapeutique
Dr Marie-Ange Mourret-Reynier

19:05 Débat/Discussion – Réponses aux questions
 
19:25 Conclusion et remerciements
 

 

Shooting date : 2025-03-25
Last update : 2025-03-31

Suggestions

Wednesday, April 20th 2022 from 06pm to 07:30pm (GMT+2)
Honolulu : Wednesday, April 20th 2022 from 06am to 07:30am (GMT+2)
San Francisco : Wednesday, April 20th 2022 from 09am to 10:30am (GMT+2)
New York : Wednesday, April 20th 2022 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Wednesday, April 20th 2022 from 01pm to 02:30pm (GMT+2)
Reykjavik : Wednesday, April 20th 2022 from 04pm to 05:30pm (GMT+2)
London / Dublin : Wednesday, April 20th 2022 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Wednesday, April 20th 2022 from 06pm to 07:30pm (GMT+2)
Istanbul : Wednesday, April 20th 2022 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Wednesday, April 20th 2022 from 08pm to 09:30pm (GMT+2)
Bangkok : Wednesday, April 20th 2022 from 11pm to 12:30am (GMT+2)
Shanghai : Thursday, April 21st 2022 from 12am to 01:30am (GMT+2)
Tokyo : Thursday, April 21st 2022 from 01am to 02:30am (GMT+2)
Sydney : Thursday, April 21st 2022 from 03am to 04:30am (GMT+2)
Wellington : Thursday, April 21st 2022 from 05am to 06:30am (GMT+2)

Cancer du sein

Cycle de formation en oncologie gynécologique et sénologique de l’Institut Curie

Share
Thursday, October 13th 2022 from 06pm to 07pm (GMT+2)
Honolulu : Thursday, October 13th 2022 from 06am to 07am (GMT+2)
San Francisco : Thursday, October 13th 2022 from 09am to 10am (GMT+2)
New York : Thursday, October 13th 2022 from 12pm to 01pm (GMT+2)
Buenos Aires : Thursday, October 13th 2022 from 01pm to 02pm (GMT+2)
Reykjavik : Thursday, October 13th 2022 from 04pm to 05pm (GMT+2)
London / Dublin : Thursday, October 13th 2022 from 05pm to 06pm (GMT+2)
Paris / Berlin : Thursday, October 13th 2022 from 06pm to 07pm (GMT+2)
Istanbul : Thursday, October 13th 2022 from 07pm to 08pm (GMT+2)
Moscou / Dubaï : Thursday, October 13th 2022 from 08pm to 09pm (GMT+2)
Bangkok : Thursday, October 13th 2022 from 11pm to 12am (GMT+2)
Shanghai : Friday, October 14th 2022 from 12am to 01am (GMT+2)
Tokyo : Friday, October 14th 2022 from 01am to 02am (GMT+2)
Sydney : Friday, October 14th 2022 from 03am to 04am (GMT+2)
Wellington : Friday, October 14th 2022 from 05am to 06am (GMT+2)

Les inhibiteurs de tyrosine kinase (TKI) et les anticorps conjugués (ADC) dans le cancer du sein mÃ...

Les nouveaux traitements, entre choix et complémentarité

Share
Tuesday, March 28th 2023 from 07pm to 08:30pm (GMT+2)
Honolulu : Tuesday, March 28th 2023 from 07am to 08:30am (GMT+2)
San Francisco : Tuesday, March 28th 2023 from 10am to 11:30am (GMT+2)
New York : Tuesday, March 28th 2023 from 01pm to 02:30pm (GMT+2)
Buenos Aires : Tuesday, March 28th 2023 from 02pm to 03:30pm (GMT+2)
Reykjavik : Tuesday, March 28th 2023 from 05pm to 06:30pm (GMT+2)
London / Dublin : Tuesday, March 28th 2023 from 06pm to 07:30pm (GMT+2)
Paris / Berlin : Tuesday, March 28th 2023 from 07pm to 08:30pm (GMT+2)
Istanbul : Tuesday, March 28th 2023 from 08pm to 09:30pm (GMT+2)
Moscou / Dubaï : Tuesday, March 28th 2023 from 09pm to 10:30pm (GMT+2)
Bangkok : Wednesday, March 29th 2023 from 12am to 01:30am (GMT+2)
Shanghai : Wednesday, March 29th 2023 from 01am to 02:30am (GMT+2)
Tokyo : Wednesday, March 29th 2023 from 02am to 03:30am (GMT+2)
Sydney : Wednesday, March 29th 2023 from 04am to 05:30am (GMT+2)
Wellington : Wednesday, March 29th 2023 from 06am to 07:30am (GMT+2)

La prise en charge des cancers du sein triple négatifs :

intégration des innovations thérapeutiques dans les algorithmes et gestion des effets secondaires

Share
Wednesday, May 10th 2023 from 06pm to 07:30pm (GMT+2)
Honolulu : Wednesday, May 10th 2023 from 06am to 07:30am (GMT+2)
San Francisco : Wednesday, May 10th 2023 from 09am to 10:30am (GMT+2)
New York : Wednesday, May 10th 2023 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Wednesday, May 10th 2023 from 01pm to 02:30pm (GMT+2)
Reykjavik : Wednesday, May 10th 2023 from 04pm to 05:30pm (GMT+2)
London / Dublin : Wednesday, May 10th 2023 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Wednesday, May 10th 2023 from 06pm to 07:30pm (GMT+2)
Istanbul : Wednesday, May 10th 2023 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Wednesday, May 10th 2023 from 08pm to 09:30pm (GMT+2)
Bangkok : Wednesday, May 10th 2023 from 11pm to 12:30am (GMT+2)
Shanghai : Thursday, May 11th 2023 from 12am to 01:30am (GMT+2)
Tokyo : Thursday, May 11th 2023 from 01am to 02:30am (GMT+2)
Sydney : Thursday, May 11th 2023 from 03am to 04:30am (GMT+2)
Wellington : Thursday, May 11th 2023 from 05am to 06:30am (GMT+2)

Cancer du sein : actualités et essais en cours, vers où allons-nous ?

Share
Scroll Up